Clinical trial · Observational
Identification and Characterisation of Sleep Disorders in a Population of Patients With Non-small Cell Lung Cancer
NCT06495346CI-TRIAL-00114608SomOncoPcompletedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This exploratory study will identify and characterise disorders frequently reported by patients as contributing to or altering their quality of life. This will enable a decision tree to be drawn up for diagnosis, referral and treatment of the sleep disorders collected, tailored to patients in this population. This decision tree should help to improve the management of patients with a cancer diagnosis presenting with sleep disorders.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cell Lung Cancer | — | UNRESOLVED | — |
| Sleep Disorders | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| self-questionnaires exploring | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Score sleep quality criteria (Pittsburgh Sleep Quality Index)
- timeFrame
- Every 14 days for 2 months
- description
- The overall score ranging from 0 to 21 points. A score of 0 means that there is no difficulty sleeping, and 21 indicates, on the contrary, major difficulties.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patient aged 18 and over. * Being monitored and treated for non-small cell lung cancer. * With or without ongoing cancer-specific treatment. With no neurocognitive impairment (MoCA test score ≥26/30). * With a clinically assessed life expectancy of more than 3 months (Royal Marsden Hospital 0-1) and general health (ECOG \<2). * Able to understand the study documents written in French * Able to complete the study questionnaires written in French. * Contactable by telephone throughout the study * Affiliated to a social security scheme or entitled beneficiary * Not opposed to taking part in the study Exclusion Criteria: * Patient refusing to take part in the study * With a mental illness of the psychosis type monitored and treated prior to the study * Patient under guardianship or curatorship * Patient under court protection
References
Publications (0)
Data not yet available
No reference posted for this study.